Results of the feasibility stage of stampede: a multiarm, multi-stage phase II/III trial for patients with high risk prostate cancer (ISRCTN78818544) [Abstract]

Clarke, N. W., Sydes, M. R., Dearnaley, D., Mason, Malcolm David ORCID: https://orcid.org/0000-0003-1505-2869, Morgan, R. C., Sanders, K., Anderson, J., Popert, R., Masters, J., Parmar, M. and James, N. D. 2008. Results of the feasibility stage of stampede: a multiarm, multi-stage phase II/III trial for patients with high risk prostate cancer (ISRCTN78818544) [Abstract]. European Urology Supplements 7 (3) , p. 233. 10.1016/S1569-9056(08)60648-X

Full text not available from this repository.

Abstract

Most drug trials in prostate cancer (PCa) concentrate on patients withhormone refractory disease. Drugs which work later in the disease may work better still if used earlier. STAMPEDE is an academic, investigator-initiated randomised controlled trial to test six treatment approaches for patients with high-risk localised or metastatic PCa who are commencing long-termhormone therapy (HT).

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Additional Information:	23rd Annual Congress of the European Association of Urology
Publisher:	Elsevier
ISSN:	1569-9056
Last Modified:	18 Oct 2022 14:21
URI:	https://orca.cardiff.ac.uk/id/eprint/17219

Actions (repository staff only)

Edit Item